• #11 - Catherine Stehman-Breen: Innovating an "On" and "Off" Switch for Cell and Gene Therapy

  • Nov 12 2020
  • Durée: 29 min
  • Podcast

#11 - Catherine Stehman-Breen: Innovating an "On" and "Off" Switch for Cell and Gene Therapy

Écouter gratuitement

Voir les détails du balado

  • Résumé

  • Imagine if you could turn the characteristics of a cell on and off… or up and down like a volume trigger… constantly tuning things until everything is working just right. It might sound impossible, but that’s exactly what Obsidian therapeutics is working on.

    I’ll admit, it was tough for me to wrap my mind around this one at first, but my guest today did a fantastic job of explaining things. So without further ado, chief development officer of Obsidian therapeutics, Catherine Stehman-Breen.

    Podcast notes and transcript available here: https://simplebiotechpodcast.com/catherine-stehman-breen-obsidian-therapeutics

    -James Ruhle, SimpleBioTechPodcast.com

    Stay up to date with the latest episodes and BioTech updates by following me on instagram @SimpleBioTech

    If you want to know which BioTech companies I'm currently excited about, connect with me on Angel List at Angel.co/jamesruhle
    Voir plus Voir moins
Voir plus Voir moins

Ce que les auditeurs disent de #11 - Catherine Stehman-Breen: Innovating an "On" and "Off" Switch for Cell and Gene Therapy

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.

Évaluations sur Audible.ca

Évaluations sur Amazon.ca
Il n'y a pas encore de critiques pour ce titre.